Clinical Trial

Long-term Follow-up Study of BRL-101 for TDT

Name: Long-term Follow-up Study of BRL-101 for TDT — clinical trial record (NCT06298630)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

Observe long-term safety risk and long-term efficacy after intravenous infusion of BRL-101 in TDT subjects.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2024-03-01; most recent amendment 2026-07-20.

Status change: Not Yet Recruiting → Recruiting 2026-07-20

Trial Details

NCT Number	NCT06298630
Lead Sponsor	Bioray Laboratories Collaborators: First Affiliated Hospital of Guangxi Medical University, Xiangya Hospital of Central South University, Chinese Academy of Medical Sciences, Nanfang Hospital, Southern Medical University, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army, Shenzhen Children's Hospital
Conditions	Thalassemia, Beta
Enrollment	45 participants
Start Date	2024-12-08
Primary Completion	2038-08-20 (estimated)
Study Completion	2038-10-15 (estimated)
Updated on ClinicalTrials.gov	2026-07-21